These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 7751878)

  • 41. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
    Tomaszewski MM; Lupton GP; Krishnan J; May DL
    J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey.
    Baykal C; Kılıç Sayar S; Yazganoğlu KD; Büyükbabani N
    Turk J Haematol; 2021 Feb; 38(1):49-56. PubMed ID: 33389922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
    Kadin ME
    Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary cutaneous CD30(+) lymphoproliferative disorders.
    Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary cutaneous CD30-positive lymphoproliferative disorders.
    Willemze R; Meijer CJ
    Hematol Oncol Clin North Am; 2003 Dec; 17(6):1319-32, vii-viii. PubMed ID: 14710887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma.
    Yagi H; Tokura Y; Furukawa F; Takigawa M
    J Invest Dermatol; 1996 Dec; 107(6):827-32. PubMed ID: 8941669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype.
    de Bruin PC; Beljaards RC; van Heerde P; Van Der Valk P; Noorduyn LA; Van Krieken JH; Kluin-Nelemans JC; Willemze R; Meijer CJ
    Histopathology; 1993 Aug; 23(2):127-35. PubMed ID: 8406384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin.
    Drews R; Samel A; Kadin ME
    Semin Cutan Med Surg; 2000 Jun; 19(2):109-17. PubMed ID: 10892712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary cutaneous anaplastic large cell lymphoma.
    Brown RA; Fernandez-Pol S; Kim J
    J Cutan Pathol; 2017 Jun; 44(6):570-577. PubMed ID: 28342276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
    Collins K; Gu J; Aung PP; Nagarajan P; Curry JL; Huen A; Ivan D; Prieto VG; Tetzlaff MT; Duvic M; Miranda RN; Vega F; Torres-Cabala CA
    Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
    Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
    Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L.
    Sigel JE; Hsi ED
    Mod Pathol; 2000 Apr; 13(4):446-51. PubMed ID: 10786813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
    Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
    Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD8-positive lymphomatoid papulosis (type D): Some lesions may lack CD30 expression and overlap histologically with mycosis fungoides.
    Simo OC; Warren SJ; Mark L; Hoffmann K; Alomari AK
    Int J Dermatol; 2019 Jul; 58(7):800-805. PubMed ID: 30520526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression.
    Gill K; Ariyan C; Wang X; Brady MS; Pulitzer M
    J Surg Oncol; 2014 Sep; 110(3):258-64. PubMed ID: 24891295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.
    Abdulla FR; Zhang W; Wu X; Honda K; Qin H; Cho H; Querfeld C; Zain J; Rosen ST; Chan WC; Parekh V; Song JY
    JID Innov; 2022 Jan; 2(1):100068. PubMed ID: 34977845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment.
    Kempf W; Kerl K; Mitteldorf C
    Semin Cutan Med Surg; 2018 Mar; 37(1):24-29. PubMed ID: 29719017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.